The Artificial Intelligence-Driven Drug Design (AIDD) module, as part of our ADMET Predictor platform, automates the drug design process by integrating our advanced generative chemistry algorithms with our best-in-the-industry high-throughput PBPK (powered by GastroPlus® ACAT model) and ADMET predictions.